Since 1959 the avian flu virus H5N1 has been popping up around the globe. Now scientists believe it could spark the next ...
Ensitrelvir reduced transmission of SARS-CoV-2 by 67% when given to uninfected household contacts of a person with COVID-19 ...
We are delighted by Ajay’s return to the Board of Invivyd as the company prepares to take the next step forward in scaling the medical benefit from its core technologies. Invivyd has rapidly ...
Preeti Joshi co-founded Fast Sense Innovations, developing Sep-Scan, a rapid sepsis detection device, aiming to transform ...
Concurrent analysis of whole-genome DNA methylation and single-cell RNA sequencing data from COVID-19 patients and controls ...
Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...
Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2. Invivyd deploys a ... authorization or ...
Vectors for Infection Risk in the United States Act (Mink VIRUS Act), bipartisan legislation endorsed by the Animal Welfare ...
Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...
Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...
The following is a summary of “A systematic review and meta-analysis of the effectiveness of remdesivir to treat SARS-CoV-2 ...
As the SARS-CoV-2 virus quickly spread around the globe, weaknesses in the world's ability to respond to an infectious disease ... executive order starting the process of withdrawing the U.S ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results